Tomasz Kucharczyk

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Advanced Non Small Cell Lung Cancer

Randomized Controlled Trial

Top Venues

Scientific reports

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Tomasz Kucharczyk, Marcin Nicoś, Marek Kucharczyk, Ewa Anna Kalinka
NRG1 Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications. Cancers 16 (15) (2024)
Tomasz Kucharczyk, Marcin Nicoś, Marek Kucharczyk, Ewa Anna Kalinka
NRG1 Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications. Cancers 16 (15) (2024)
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz Mirosław Kowalski, Adam Płużański, Tomasz Kubiatowski, Ewa Anna Kalinka
RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy. Cancers 14 (21) (2022)
Natalia Krzyżanowska, Paweł Krawczyk, Kamila Wojas-Krawczyk, Tomasz Kucharczyk, Janusz Milanowski
Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy? Cells 11 (20) (2022)
Kamila Wojas-Krawczyk, Iwona Paśnik, Tomasz Kucharczyk, Irena Wieleba, Natalia Krzyżanowska, Michał Gil, Paweł Krawczyk, Janusz Milanowski
Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy. International journal of molecular sciences 22 (17) (2021)
Paweł Krawczyk, Anna Grenda, Paulina Terlecka, Justyna Błach, Kamila Wojas-Krawczyk, Tomasz Kucharczyk, Izabela Chmielewska, Robert Kieszko, Bożena Jarosz, Michał Gil, Katarzyna Reszka, Janusz Milanowski
Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement. Scientific reports 11 (1) (2021)